Key points are not available for this paper at this time.
The current investigation revealed a novel role for SIRT3 in oral cancer carcinogenesis as a promoter of cell proliferation and survival, thus implicating SIRT3 as a new potential therapeutic target to treat oral cancer.
Alhazzazi et al. (2010) studied this question.